Direct answer:The application of the 510(k) exemption is judged first on the basis of the intended use of the product, technical characteristics, product codes and classification regulations; If exemption is not applicable, 510(k), De Novo, PMA or other applicable paths are re-evaluated. Declarations cannot be determined directly by the name of the device, risk level, registration number or “no equivalent product”.
I. Determination of product facts and classification bases first
Collapse the intended use, adaptation, target population, use of the environment, working principles, materials, exposure to humans, models and label declarations, and search the FDA Production database to match product codes, classification codes and corresponding descriptions.
The level of risk is an important clue, but it is not a substitute for specific classification legislation. Products with similar names may also be subject to different requirements depending on their use, technology or user. Data preparation and classification can be obtained fromClassification and Path AssessmentStart.
II. How can it be judged that 510(k) exemptions apply?
Most Category I and Part II devices may be exempted from 510(k), but matching classification codes, product exclusivity conditions and exemptions should be read at the same time. Different applications and the application of different basic science and technology may result in products going beyond the exemption.
It is recommended that the product information version, the product code, the regulatory number, the date of the query and the item-by-item description of the use and technical consistency be retained. The lack of clarity continues to be verified and the word “Exempt” in the database cannot be taken to conclude.
Exemptions are usually judged by statute and product facts and are not a uniform “certificate of immunity” application procedure. If the need for information is assessed and the follow-up is sorted, you can check it.510(k) Exemption assessment and compliance support。
3. What is a 510(k) submission for?
Projects to which 510(k) applies usually need to prove material equivalence by comparing them with appropriate legal listings (predicate). The intended use, technical characteristics, and whether differences give rise to new security or effectiveness issues and what support information is required should be checked.
Comparable devices cannot be selected solely on the basis of a trade name of the same kind or information on the business register. The scope of testing and documentation needs to be identified in conjunction with products, technical differences and applicable guidelines; Obtaining a establishment registration or product listing is not equal to obtaining 510(k) clearance. See range of services.510(k) Declaration support。
iv. Do you have to leave De Novo without a proper predicate?
This cannot be judged directly. De Novo is a path for the establishment of appropriate classification for devices that are not legally listed as predicate but which can provide reasonable security assurance through general or special controls, and is assessed in conjunction with product risk and evidence.
De Novo cannot be considered suitable simply because the product is “innovated” or because the same name has not been found. The adequacy of the search and classification should be confirmed before controls, tests and clinical information that may be required are assessed. See work on this.De Novo Category Application for Services。
What's the difference between the PMA and the first two paths?
PMA is an important pre-market approval route for the application of high-risk devices and requires effective scientific evidence to support reasonable assurance of safety and effectiveness of the intended use. The specific need for PMA shall be determined in accordance with the regulations on the classification of instruments and the applicable requirements.
PMA is not just a few more documents than 510(k). Research, clinical evidence, manufacturing quality and follow-up maintenance arrangements may differ significantly and should be clearly developed and declared at an early stage. ViewablePMA Pre-market approval for services。
VI. What remains after exemptions or pre-market decisions?
The applicable obligations of establishment registration, Device Listing, offshore facilities U.S. agent, labels, UDI, QMSR, complaints and adverse events still need to be assessed separately. (a) The requirement is exempt and does not represent a synchronized exemption for other items; The responsibilities of different enterprises may also differ.
CombinableBusiness register and Device Listing guideandQMSR Elements of ApplicationOrganization of follow-up work. Registered listing services should be identified separately from the listed route technical assessment.
VII. What is to be prepared before the assessment, and how is the periodicity and cost judged?
- Product uses, adaptive conditions, users, environment, technical principles and model variations.
- Labels and instructions, structure or material information, software and key energy information (if applicable).
- To match product codes, regulations, candidates predicate and search records.
- Tests, risk analysis, clinical or quality information and their gaps are available.
- Manufacturers, labelers, importers, etc., and FDA transactions are recorded.
A distinction is made between route assessment, supplementary research, document production and official processing time, and then a plan is agreed upon. Official fees and services vary from one path to another, and a statement of the cycle costs of the corresponding service page should be viewed; The annual fees for establishment registration are not the same as those claimed by 510(k), De Novo or PMA.
An initial communication can provide a summary of the product and a catalogue of information; Confidential technical information is provided after clear authorization and handover arrangements have been made.
Official sources and next entry points
- FDA | medical classification
- FDA | I and II equipment exemptions and restrictions
- FDA|Premarket Notification 510(k)
- FDA | de Novo classification application
- FDA | PMA prior to listing
Enterprises identified as requiring assessment exemptions, accessible510(k) Exemptions to services; When a path has not yet been established, communication between classification and product facts should be undertaken to avoid the use of generic business registers as publicly declared project quotations.
View Device Classification and Path Assessment Service
Submission of product summaries, communication of listing routes
Official data checks and updates: 2026-11-06. Author: Mr. Otsun; Audit: Mr. Toto. Specific classification, exemptions and declaration pathways depend on the complete product facts and current requirements.
Continue reading and preparation
- Medical record establishment registration and Device Listing
- What's FDA QMSR? 21 CFR Part 820 and ISO 13485
Further consolidation of project information is available510(k) Exemption assessment and compliance support; The scope, processing cycles and costs are shown on the corresponding service page.